Our Drugs and Medical Devices

<p>At Provepharm, we reinvent&nbsp;the model of pharmaceutical innovation and contribute to improve, day after day, the hospital practices and speciality care offered to patients.</p>

<ul> <li>We are <strong>a Private&nbsp;French Pharmaceutical Company&nbsp;</strong>and our products are distributed in more than 30 countries worldwide.</li> <li>Our products, <strong>which meet the highest pharmaceutical quality standards</strong>, are available in&nbsp;hospitals worldwide through an international distribution network.</li> </ul>

Gamme de produits

Methylthioninium chloride Proveblue 5 mg/ml, solution for injection Europe

<p><em>Please note: products are available in some EMA countries.</em></p>

ProvayBlue® Methylene blue United States

Proveblue® methylene blue 50 mg/10 mL, solution for injection New-Zealand

PROVEBLUE® (methylene blue solution for injection) Australia

Proveblue injection 0.5% (Methylene Blue) South Korea

PROVEBLUE® 5 mg/mL, solution for injection Singapore

ProvEndo® 0.8% Indigo Carmine Europe - Endoscopic coloring agent

<p>Medical device class IIa</p> <p><em>Please note: products are available in some EMA countries.</em></p>

ProveDye® 0.5% Methylene Blue - 2ml and 10 ml Europe - Surgical coloring agent

<p>Medical device class IIa</p> <p><em>Please note: products are available in some EMA countries.</em></p>

VITAMIN A PROVEPHARM 100 000 I.U. / 2 ml, solution for injection (I.M.) France

<p>Retinol palmitate (vitamin A)</p>

VITAMIN E PROVEPHARM 100 mg / 2 ml, solution for injection (I.M) France

<p>Alpha-tocopherol acetate (vitamin E)</p> <p>&nbsp;</p>

FEGENOR 140 mg, capsules France

<p>fenofibrate</p>

QUITAXON 10 mg, film-coated tablets France

<p>doxepin</p>

QUITAXON 50 mg, film-coated tablets France

<p>doxepin</p>

<p>For residents in France, please access our dedicated products page <a href="https://provepharm.com/Nos-produits">by clicking here</a>.</p>

You are about to leave the Provepharm Corporate website. If you continue you will reach the website of our US subsidiary which the information is not necessarily applicable to France.